SPONSORED
By Elric Langton | 8 November 2022
I have a financial interest in Poolbeg Pharma Plc.
Poolbeg Pharma (AIM: POLB, OTCQB: POLBF), a clinical-stage infectious disease pharmaceutical company with a unique capital-light clinical model, announces that it has made a significant breakthrough in its Artificial Intelligence (AI) Programme with partner OneTβ¦